Halozyme Therapeutics is appointing David Ramsay Interim Chief Financial Officer (CFO), effective March 23, 2026.
Will advance the biotech company's lead antibody-drug conjugate (ADC) program.
BioDuro, a global CRDMO, has appointed Andrew Thomas, Ph.D., and Stevan Djuric, Ph.D., as scientific advisors.
Fujifilm Biotechnologies has appointed Christiane Bardroff as Chief Business Officer (CBO), effective June 1, 2026.
SK pharmteco has announced the successful CGMP qualification of its manufacturing facility in Corbeil-Essonnes, France.
Trenchant BioSystems Inc. and Invetech have entered into a strategic alliance focused on the continued development of Trenchant’s fully automated AutoCell Platform.
Coriolis Pharma has opened a new U.S. headquarters and laboratory at the Alexandria Center for Advanced Technologies in North Carolina’s Research Triangle Park.
Agilent Technologies is launching Agilent Advanced Therapeutics, a unified CDMO solution integrating capabilities in Canada and the U.S.
Bespak is increasing pressurized metered dose inhaler manufacturing capacity to support Chiesi Group’s Carbon Minimal Inhaler (CMI) program.
Novo Nordisk has signed an agreement with Hims & Hers Health that will allow the telehealth provider to offer FDA‑approved ...
Colbert Packaging Corporation, a manufacturer of custom paperboard folding cartons, labels, and inserts, has installed an ...
NewcelX Ltd., a clinical-stage company, has entered a strategic collaboration with Eledon Pharmaceuticals Inc., a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results